XORTX regains Nasdaq compliance after reverse stock split Apr 21, 2026 07:02AM
XORTX extends deadline to complete Vectus acquisition to March Feb 4, 2026 06:01PM
XORTX Therapeutics Inc (XRTX) Announces USD $3 Million Offering Up to 3.4 Million Shares at $0.88 Each May 19, 2025 07:02AM
XORTX Therapeutics Inc (XRTX) Provides Update on FDA Type B Meeting Request Apr 30, 2025 07:02AM
XORTX Therapeutics Inc (XRTX) Commences Gout Program NDA Discussions with the FDA Feb 24, 2025 07:03AM


Jan 6, 2025 07:03AM XORTX Therapeutics Inc (XRTX) Adds Late Stage Gout Program to Pipeline
Oct 17, 2024 08:01AM XORTX Therapeutics Inc (XRTX) Announces 810.81K Share Offering at $2.18/sh